The effect of radical treatment and rehabilitation on muscle mass and strength: A randomized trial in stages I-III lung cancer patients

Lung Cancer

Volumn 84, Issue 1, 2014, Pages 56-61

  Salhi, B ^a   Huysse, W ^a   Van Maele, G ^b   Surmont, V F ^a   Derom, E ^a   van Meerbeeck, J P ^a,c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Body composition; Lung cancer; Muscle weakness; Radical treatment

Indexed keywords

AGED; ARTICLE; BODY MASS; CANCER PATIENT; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DYNAMOMETER; FAT FREE MASS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; IMPEDANCE; LUNG CANCER; MALE; MULTICENTER STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; MUSCLE MASS; MUSCLE STRENGTH; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY REHABILITATION; QUADRICEPS FEMORIS MUSCLE; RADICAL TREATMENT; RANDOMIZED CONTROLLED TRIAL;

BODY COMPOSITION; LUNG CANCER; MUSCLE WEAKNESS; RADICAL TREATMENT;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; NEOPLASM STAGING; ORGAN SIZE; RISK FACTORS;

EID: 84896696027     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.01.011     Document Type: Article

References (44)

1. Argiles J.M., Busquets S., Felipe A., Lopez-Soriano F.J. Muscle wasting in cancer and ageing: cachexia versus sarcopenia. Adv Gerontol 2006, 18:39-54.
2. Muscaritoli M., Bossola M., Aversa Z., Bellantone R., Fanelli F.R. Prevention and treatment of cancer cachexia: new insights into an old problem. Eur J Cancer 2006, 42(1):31-41.
3. Al-Majid S., Gray D.P. A biobehavioral model for the study of exercise interventions in cancer-related fatigue. Biol Res Nurs 2009, 10(4):381-391.
4. Argiles J.M., Busquets S., Garcia-Martinez C., Lopez-Soriano F.J. Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future. Nutrition 2005, 21(9):977-985.
5. Vigano A., Bruera E., Jhangri G.S., Newman S.C., Fields A.L., Suarez-Almazor M.E. Clinical survival predictors in patients with advanced cancer. Arch Intern Med 2000, 160(6):861-868.
6. Prado C.M.M., Baracos V.E., McCargar L.J., Mourtzakis M., Mulder K.E., Reiman T., et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 2007, 13(11):3264-3268.
7. Marquis K., Debigare R., Lacasse Y., Leblanc P., Jobin J., Carrier G., et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 166(6):809-813.
8. Schols A.M.W.J., Broekhuizen R., Weling-Scheepers C.A., Wouters E.F. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005, 82(1):53-59.
9. Anker S.D., Ponikowski P., Varney S., Chua T.P., Clark A.L., WebbPeploe K.M., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997, 349(9058):1050-1053.
10. Staal-van den Brekel A.J., Schols A.M., Dentener M.A., Ten Velde G.P., Buurman W.A., Wouters E.F. Metabolism in patients with small cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls. Thorax 1997, 52(4):338-341.
11. Jatoi A., Daly B.D.T., Hughes V.A., Dallal G.E., Kehayias J., Roubenoff R. Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure?. Ann Thorac Surg 2001, 72(2):348-351.
12. van W.E., Hoekstra-Weebers J., Otter R., Postema K., Sanderman R., van der S.C. Cancer-related fatigue: predictors and effects of rehabilitation. Oncologist 2006, 11(2):184-196.
13. Yavuzsen T., Davis M.P., Ranganathan V.K., Walsh D., Siemionow V., Kirkova J., et al. Cancer-related fatigue: central or peripheral?. J Pain Symptom Manage 2009, 38(4):587-596.
14. Peddle-McIntyre C.J., Bell G., Fenton D., McCargar L., Courneya K.S. Feasibility and preliminary efficacy of progressive resistance exercise training in lung cancer survivors. Lung Cancer 2012, 75(1):126-132.
15. Maddocks M., Armstrong S., Wilcock A. Exercise as a supportive therapy in incurable cancer: exploring patient preferences. Psychooncology 2011, 20(2):173-178.
16. Kyle U.G., Bosaeus I., De Lorenzo A.D., Deurenberg P., Elia M., Gomez J.M., et al. Bioelectrical impedance analysis principles and methods. Clin Nutr 2004, 23(5):1226-1243.
17. Hansen R.D., Williamson D.A., Finnegan T.P., Lloyd B.D., Grady J.N., Diamond T.H., et al. Estimation of thigh muscle cross-sectional area by dual-energy X-ray absorptiometry in frail elderly patients. Am J Clin Nutr 2007, 86(4):952-958.
18. Bernard S., Leblanc P., Whittom F., Carrier G., Jobin J., Belleau R., et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary-disease. Am J Respir Crit Care Med 1998, 158(2):629-634.
19. Simons J.P., Schols A.M., Westerterp K.R., Ten Velde G.P., Wouters E.F. The use of bioelectrical impedance analysis to predict total body water in patients with cancer cachexia. Am J Clin Nutr 1995, 61(4):741-745.
20. Knols R.H., Aufdemkampe G., de Bruin E.D., Uebelhart D., Aaronson N.K. Hand-held dynamometry in patients with haematological malignancies: measurement error in the clinical assessment of knee extension strength. BMC Musculoskelet Disord 2009, 10.
21. Salhi B., Derom E., van Meerbeeck J. ClinicalTrials.gov: NCT00752700: Resistance Exercise Training For Radically Treated Respiratory Cancer (REINFORCE) 2008.
22. Mattsson S., Thomas B.J. Development of methods for body composition studies. Phys Med Biol 2006, 51(13):R203-R228.
23. Schols A.M., Soeters P.B., Dingemans A.M., Mostert R., Frantzen P.J., Wouters E.F. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993, 147(5):1151-1156.
24. Coin A., Sergi G., Beninca P., Lupoli L., Cinti G., Ferrara L., et al. Bone mineral density and body composition in underweight and normal elderly subjects. Osteoporos Int 2000, 11(12):1043-1050.
25. Decramer M., Lacquet L.M., Fagard R., Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994, 150(1):11-16.
26. Tisdale M.J. Cachexia in cancer patients. Nat Rev Cancer 2002, 2(11):862-871.
27. Jones L.W., Eves N.D., Haykowsky M., Freedland S.J., Mackey J.R. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol 2009, 10(6):598-605.
28. Fearon K.C.H. Cancer cachexia and fat-muscle physiology. N Engl J Med 2011, 365(6):565-567.
29. Op den Kamp C.M., Langen R.C., Minnaard R., Kelders M.C., Snepvangers F.J., Hesselink M.K., et al. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system. Lung Cancer 2012, 76(1):112-117.
30. Troosters T., Casaburi R., Gosselink R., Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005, 172(1):19-38.
31. Newman A.B., Kupelian V., Visser M., Simonsick E.M., Goodpaster B.H., Kritchevsky S.B., et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A: Biol Sci Med Sci 2006, 61(1):72-77.
32. Al-Majid S., McCarthy D.O. Cancer-induced fatigue and skeletal muscle wasting: the role of exercise. Biol Res Nurs 2001, 2(3):186-197.
33. Granger C.L., McDonald C.F., Berney S., Chao C., Denehy L. Exercise intervention to improve exercise capacity and health related quality of life for patients with non-small cell lung cancer: a systematic review. Lung Cancer 2011, 72(2):139-153.
34. Arbane G., Tropman D., Jackson D., Garrod R. Evaluation of an early exercise intervention after thoracotomy for non-small cell lung cancer (NSCLC), effects on quality of life, muscle strength and exercise tolerance: randomised controlled trial. Lung Cancer 2011, 71(2):229-234.
35. Salhi B., Demedts I., Simpelaere A., Decraene S., Vermeulen K., Surmont V., et al. Endurance and resistance training in radically treated respiratory cancer patients. Rehabil Res Pract 2010, 2010. 7 pp.
36. Schmitz K.H., Courneya K.S., Matthews C., Demark-Wahnefried W., Galvao D.A., Pinto B.M., et al. American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010, 42(7):1409-1426.
37. Di Sebastiano K.M., Mourtzakis M. A critical evaluation of body composition modalities used to assess adipose and skeletal muscle tissue in cancer. Appl Physiol Nutr Metab 2012, 37:811-821.
38. Salhi B., Haenebalcke C., Perez-Bogerd S., Nguyen M., Ninane V., Malfait M., et al. Effect of resistance training on maximal exercise capacity and muscle force in patients with radically treated intrathoracic cancer (REINFORCE) 2013, ERS, 7-9-2013, Abstract nr: 2840.
39. Kisiel-Sajewicz K., Davis M.P., Siemionow V., Seyidova-Khoshknabi D., Wyant A., Walsh D., et al. Lack of muscle contractile property changes at the time of perceived physical exhaustion suggests central mechanisms contributing to early motor task failure in patients with cancer-related fatigue. J Pain Symptom Manage 2012, 44(3):351-361.
40. Bruera E., Brenneis C., Michaud M., Jackson P.I., Macdonald R.N. Muscle electrophysiology in patients with advanced breast-cancer. J Natl Cancer Inst 1988, 80(4):282-285.
41. Staal-van den Brekel A.J., Schols A.M., Dentener M.A., Ten Velde G.P., Buurman W.A., Wouters E.F. The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma. Br J Cancer 1997, 76(12):1630-1635.
42. van Kreel B.K., Cox-Reyven N., Soeters P. Determination of total body water by multifrequency bio-electric impedance: development of several models. Med Biol Eng Comput 1998, 36(3):337-345.
43. Fredrix E.W.H.M., Soeters P.B., Vonmeyenfeldt M.F., Saris W.H.M. Measurement of resting energy-expenditure in a clinical setting. Clin Nutr 1990, 9(6):299-304.
44. Kyle U.G., Bosaeus I., De Lorenzo A.D., Deurenberg P., Elia M., Gomez J.M., et al. Bioelectrical impedance analysis-Part I: Review of principles and methods. Clin Nutr 2004, 23(5):1226-1243.